UFJ Capital Overview

  • Investor Type
  • Venture Capital
  • Status
  • Inactive
  • Investments
  • 3
  • Portfolio
  • 1
  • Exits
  • 2

UFJ Capital General Information


UFJ Capital was a venture capital firm that was based in Tokyo, Japan. The firm used to make venture capital investments.

Contact Information

Investor Status
Out of Business
Primary Investor Type
Venture Capital
Primary Office
  • 1-7-17 Nihonbashi
  • Nihonbashi Miyuki Building 6F, Chuo-ku
  • Tokyo, 103-0027
  • Japan

UFJ Capital Investments (3)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Epsilon Molecular Engineering 23-Dec-2020 Early Stage VC 00.000 Biotechnology Startup 00000000 000000000
00000000 04-Sep-2020 00000 00000 00.000 Consulting Services (B2B) Generating Revenue
0000000 0000000000 11-Oct-2002 00000 00000 000.00 Pharmaceuticals Profitable
To view UFJ Capital’s complete investments history, request access »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

UFJ Capital Exits (2)

Company Name Exit Date Exit Type Exit Size
ClipLine 20-Jul-2021 Secondary Transaction - Private
0000000 0000000000 02-Aug-2007 000 000.00
To view UFJ Capital’s complete exits history, request access »

UFJ Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

UFJ Capital Co-Investors (5)

Name With Exits Lead Partner Series Industry
Anniversaire Holdings 1 0 Series chart Industry bar
Gunma Medical Engineering Vitalization Investments 0 0 Series chart Industry bar
Real Tech Holdings 0 0 Series chart Industry bar
SMBC Venture Capital 0 0 0 Series chart Industry bar
Sunbridge (IT Consulting and Outsourcing) 0 0 0 Series chart Industry bar
To view UFJ Capital’s complete co-investors history, request access »